Success Story: Overcoming an RFE to Secure EB-1A Approval for a Senior Scientist Advancing Biochemistry Research
Client’s Testimonial:
"Thanks for the support!”
On July 6th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Scientist in the Field of Biochemistry (Approval Notice).
General Field: Biochemistry
Position at the Time of Case Filing: Senior Scientist
Country of Origin: China
State of Residence at the Time of Filing: Maryland
Approval Notice Date: July 6th, 2026
Processing Time: 27 months, 7 days
Case Summary:
Obtaining approval under the EB-1A category requires more than demonstrating a strong publication record or research credentials. USCIS ultimately evaluates whether the evidence, taken as a whole, establishes sustained national or international acclaim and shows that the applicant has risen to the very top of the field. In this case, the client, a Senior Scientist working in biochemistry, received a Request for Evidence (RFE) primarily challenging whether the client's original scientific contributions were of major significance. Working closely with the client, North America Immigration Law Group (Chen Immigration Law Associates) developed a comprehensive response that focused on demonstrating the real-world influence of the client's research rather than relying solely on numerical achievements.
Our strategy emphasized how the client's research resolved longstanding scientific bottlenecks in molecular biology and genetic regulation while directly contributing to broader efforts to combat drug-resistant pathogens and advance novel therapeutics. Rather than presenting the research as isolated academic accomplishments, we demonstrated how independent investigators had actively incorporated the client's findings into subsequent studies and applied biotechnology. By tracing this chain of downstream reliance, we illustrated that the client's work functions as a critical scientific foundation upon which other experts continue to build.
To reinforce these arguments, we organized objective evidence showing the client's sustained influence within the scientific community, including:
- A Ph.D. in Biochemistry and Molecular Biology
- 18 peer-reviewed journal articles;
- 22 reviews for journals
- Approximately 969 citations at the time of the RFE response, with the overwhelming majority coming from independent researchers;
- Service as an editorial board member for respected scientific journals
- Received funding from the Canadian Institutes of Health Research (CIHR), the Ministry of Science and Technology of China (MOST China), the National Institutes of Health (NIH), and the National Natural Science Foundation of China (NSFC)
A key aspect of the response was explaining not only that the client had been widely cited, but why those citations mattered. We highlighted examples showing that independent researchers relied on the client's discoveries to advance studies of HIV biology, bacterial genome regulation, and therapeutic development. We also incorporated expert opinions explaining how the client's work had advanced scientific understanding. As one recommender observed:
"[Client]'s work demonstrates great progress in understanding the functions of biomacromolecules and, in particular, advances our ability to address the growing problem of bacterial resistance."
Finally, we addressed the legal standards discussed in the RFE by showing how the entire body of evidence satisfied both the regulatory criteria and the final merits analysis required for EB-1A adjudications.
After 27 months and 7 days of processing, USCIS approved the client's EB-1A petition. We successfully guided the client through this challenging adjudication by presenting a carefully structured RFE response that connected objective evidence, independent expert analysis, and the broader impact of the client's work. We wish the client continued success in advancing biochemistry research and developing discoveries that support future innovations in infectious disease treatment and biotechnology.